# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001915249 (5,40,42)

Office of origin: United States of America

Date of International Registration:29 January 2026
Date of designation in the UK: 29 January 2026

The mark consists of A triangular region containing the formative "BIO" followed by the formative "SHIELD" with the formatives "LIFE SCIENCES" appearing below "SHIELD".

International priority date claimed: 29 July 2025 (United States of America) (99308340)

Class 5
  Biologics, biosimilars, biotherapeutics, and vaccines.
Class 40
  Contract manufacturing in the biotechnology field, namely, manufacturing, fill and finish of biologics and drug substances for others; custom manufacturing of biologics, biosimilars, biotherapeutics, vaccines and cell and gene therapies; consulting services concerning custom manufacturing of biologics, biosimilars, biotherapeutics, vaccines and cell and gene therapies.
Class 42
  Drug development services for others, namely, biologics, biosimilars, biotherapeutics, vaccines and cell and gene therapies; consulting services for others in the areas of drug discovery and development, and preparation and submission of new drug applications and biologics license applications to governmental regulatory bodies; consulting services for others concerning development of biologics, biosimilars, biotherapeutics, vaccines and cell and gene therapies; research and development services in the biotechnology field.

Bioshield Life Sciences LLC

Representative: Joshua M. Gerben Gerben Perrott PLLC, 1050 Connecticut Ave NW, Suite 500, Washington DC 20036, UNITED STATES OF AMERICA